Related Articles
TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway
TRIP13 is expressed in colorectal cancer and promotes cancer cell invasion
Upregulation of TRIP13 promotes the malignant progression of lung cancer via the EMT pathway
Upregulation of thyroid hormone receptor interactor 13 is associated with human hepatocellular carcinoma
KIF18B promotes breast cancer cell proliferation, migration and invasion by targeting TRIP13 and activating the Wnt/β‑catenin signaling pathway